Results 31 to 40 of about 3,630,045 (162)

Xeloda as first-line therapy of metastatic colorectal cancer-our experience [PDF]

open access: yesArchive of Oncology, 2002
BACKGROUND: Results of phase III clinical studies comparing efficacy of Xeloda vs. standard 5-FU/FA protocols as first line therapy of metastatic colorectal carcinoma (MCRC), have shown better efficacy of Xeloda, with less toxic adverse effects, apart ...
Kovčin Vladimir   +4 more
doaj   +1 more source

Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers

open access: yes, 2018
The definition of antineoplastic administration sequences can help planning of therapeutic regimens in a more rational way, and thus optimize chemotherapy effects on patients, increasing efficacy and reducing toxic effects.
Juliane Carlotto (5380121)   +2 more
core   +1 more source

Compliance with a protocol for acute lymphoblastic leukemia in childhood

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2011
BACKGROUND: Remission rates achieved after the initial treatment of acute lymphoblastic leukemia may be similar in both developed and developing countries, but relapse rates are much higher in the latter.
Benigna Maria de Oliveira   +3 more
doaj   +1 more source

Nurse Safety in the Management of Antineoplastic Therapy: Scoping Review

open access: yes, 2021
Objetivo Identify and synthesize the scientific evidence on cancer nurse safety in the management of antineoplastic therapy. Question Formulation P (Population) – Oncology Nursing. C (Concept) – Occupational Safety. C (Context) – Antineoplastic Agents.
Patrícia Peres de Oliveira   +2 more
core   +2 more sources

Reproductive adverse events in patients with non‐Hodgkin lymphoma treated with chemotherapeutic regimens including cyclophosphamide, doxorubicin, vincristine, prednisone or CHOP with rituximab: A systematic review and meta‐analysis

open access: yesPediatric Discovery
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL).
Rong Han   +6 more
doaj   +1 more source

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana   +5 more
doaj   +1 more source

Representation and comparison of chemotherapy protocols with ChemoKG and graph embeddings

open access: yes
International audienceBackground: Chemotherapy, a central cancer treatment, employs antineoplastic drugs to hinder cancer cell replication by disrupting DNA synthesis or mitosis.
Sabatier, Brigitte   +6 more
core   +3 more sources

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation

open access: yesHematology, Transfusion and Cell Therapy, 2020
Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival.
Edvan De Queiroz Crusoe   +23 more
doaj   +1 more source

Complete blood count evaluation of dogs: four chemotherapy protocols

open access: yes, 2019
This retrospective study aimed to evaluate potential hematological alterations in dogs treated with four different antineoplastic ...
Lucas Kluthcovsky (6611507)
core   +1 more source

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

open access: yes, 2023
International audienceBackground: Malignancies are a major cause of late death after liver transplantation (LT). In LT recipients presenting a malignancy, antineoplastic chemotherapy is central part of the therapeutic arsenal, but management of both ...
Coupier, Antoine   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy